Table 2. Common blood tests, factors that affect the pre-analytical phase, and key recommendations.
| Name of test | Factors affecting the pre-analytical phase | Recommendations |
|---|---|---|
| Aldosterone | Posture Medications [NB1] Timing of collection |
Best time to collect is mid-morning. Indicate if sample was taken with patient upright or supine. |
| Blood film | Sample time in tube | Red cell morphology may change with prolonged time in tube. Prepare blood films on-site if delay is anticipated. |
| Blood gases | Temperature | Place on ice and transport to lab immediately. |
| Coagulation studies | Overfilled or underfilled sample tube | Fill the sample tube to the indicated line. |
| Cortisol | Diurnal variation Corticosteroid use Combined oral contraceptive pill Oral estrogen Pregnancy |
Serum cortisol (for hypocortisolism) should be taken between 8 and 10 am. Corticosteroids suppress endogenous cortisol and should be stopped 24 to 72 hours before testing. Oral estrogen raises cortisol-binding globulin and thus cortisol concentrations, and should be stopped for 6 weeks before testing. |
| Creatinine | Trimethoprim Cephalosporins (some assays only) Creatine supplements |
Stop offending agents if feasible and allow washout before retesting. Contact your laboratory for advice. |
| CrossLaps (C-terminal telopeptide) | Fasting status | Ensure patient has fasted before collection. |
| Fasting glucose | Fasting status Collection tube Delayed separation |
Fast for at least 8 hours. Use appropriate collection tube (check with laboratory). Process samples promptly. |
| Iron | Diurnal variation Fasting status |
Fasting samples are preferred, as results can be falsely elevated if not fasted. |
| Lipid studies | - | Routine fasting is not required. |
| Plasma metanephrines | Posture Caffeine Medications (MAOIs, SNRIs, SSRIs, TCAs) |
Allow patient to lie supine for 30 minutes prior to collection. Allow washout of interfering medications before testing. |
| Potassium | Haemolysis Delayed separation Leucocytosis Thrombocytosis EDTA contamination |
Take measures to reduce haemolysis. Process samples promptly. Ensure correct tube use (do not pour blood from one tube to another). |
| Renin | Cryoactivation Medications [NB1] |
Store and transport samples at room temperature. |
| Testosterone | Diurnal variation | Collect sample between 8 and 10 am, or as soon after waking as possible. |
| Thyroid function tests | Biotin | Discontinue biotin-containing supplements or products at least 1 week before testing. |
| Urea | Dehydration | Ensure patient is adequately hydrated before sample collection. |
| Vitamin A | Photolability | Protect from light (wrap in aluminium foil). |
| Vitamin C | Photolability Temperature |
Protect from light (wrap in aluminium foil). Place on ice immediately after collection. |
EDTA = ethylenediaminetetraacetic acid; MAOIs = monoamine oxidase inhibitors; SNRIs = selective noradrenaline reuptake inhibitors; SSRIs = selective serotonin reuptake inhibitors; TCAs = tricyclic antidepressants
NB1: Medications that affect renin and aldosterone concentrations include mineralocorticoid receptor antagonists, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta blockers, dihydropyridine calcium channel blockers, thiazide and loop diuretics, methyldopa and clonidine. Antihypertensives that do not interfere include verapamil, prazosin, moxonidine and hydralazine.